Wendy Chao

Takeda Pharmaceutical Company Limited - Osaka / Japan

Natural Sciences / Molecular Biology & Genetics

AD Scientific Index ID: 4446026

武田薬品工業株式会社

Registration, Add Profile,
Premium Membership

Print Your Certificate

Wendy Chao's MOST POPULAR ARTICLES

1-) IGF2: epigenetic regulation and role in development and diseaseW Chao, PA D\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'AmoreCytokine & growth factor reviews 19 (2), 111-120, 20083622008

2-) CTCF, a candidate trans-acting factor for X-inactivation choiceW Chao, KD Huynh, RJ Spencer, LS Davidow, JT LeeScience 295 (5553), 345-347, 20023602002

3-) Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitisS Bonini, A Lambiase, P Rama, F Sinigaglia, M Allegretti, W Chao, ...Ophthalmology 125 (9), 1332-1343, 20181982018

4-) Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal TrialSC Pflugfelder, M Massaro-Giordano, VL Perez, P Hamrah, SX Deng, ...Ophthalmology 127 (1), 14-26, 20202272020

5-) Clinical evidence of herb-drug interactionsC Ulbricht, W Chao, D Costa, E Rusie-Seamon, W Weissner, J WoodsCurrent drug metabolism 9 (10), 1063-1120, 20082242008

ARTICLES

Add your articles